Summary: Holds large positions in both ALLR and LITM; confident both will rise strongly in the future.

@jrsant2000 I own a lot of both of them and am confident that sodmeday in future we will see them rise strongly too imo

@SuperDuperInvst Hoping for $ALLR and $LITM 🙏🏽🙏🏽🙏🏽 make it Super Duper!


Summary: Strong buy on XAIR below $0.45 (under cash value); bullish across short, near, and long term.

structural marker; pre-classified as canonical yfinance ticker

$XAIR <$0.45 - Buying at under cash on hand value.
Time to LOAD UP for ST, NT & LT imo.
#SupDup


Summary: Big player appears to be accumulating HOVR, building a long position.

$HOVR - Looks like a big player is slowly accumulating building a long position imo.
#SupDup


Summary: Added to SOBR position on dips, anticipating a second move higher.

industry='Scientific & Technical Instruments'

$SOBR - Added more on dips for round 2 at between $0.98 - $1.15
#SupDup


Summary: Adding TSSI on dips; targets $20–$30 in 2025 and $40+ long-term.

$TSSI - I will be adding more at <$12 and on any dips for ST, NT & LT as I see stock rising to $20 - $30 sometime in 2025 and $40+ in LT. Once $15+ the buying interest will intensify just like how we saw with $AAOI that I showed last year at ~$8 which slowly went up to $45 at one point rising 500+% imo
#SupDup


start loading up if you are convinced with me on … I don't want you to missout like so many of my multi baggers recently rising 100% to 1000% quickly imo

Summary: Bullish on Richtech Robotics at $0.80, urging followers to load up for potential 100–1000% gains.

Compare me to that screamer Booyah guy or to a Paid pumper   😂  but PLEASE seriously do a lot of DD on $RR $0.80 - Richtech Robotics Inc. and if you like what you see, start loading up if you are convinced with me on  👇
I don't want you to missout like so many of my multi baggers recently rising 100% to 1000% quickly imo
#SupDup

https://t.co/xcuVpy9mlh


Summary: Adding to EDBL position below $0.25.


Summary: Aggressively buying RR; expects a major move up in 2025 or sooner.

$RR - I am LOADING UP. Don't be without if you like it.
1 day in 2025 or even sooner it could   🔥   🚀   imo.
#SupDup


Summary: Actively buying MBIO heavily on dips for short-term and near-term gains.

$MBIO ~0.22 - Buying heavily on dips for ST & NT after the earlier rise to ~$0.45
#SupDup


Summary: Bullish XAIR into 2025 on pending cardiac surgery PMA approval and new hospital/DOD/VA sales ramp.

$XAIR - Cardiac surgery PMA supplement review ongoing at FDA. Currently no FDA approved nitric oxide system is labeled for cardiac surgery
Approval would increase LungFit PH’s rate of market penetration and support long-term revenue growth per mgmt.
2025 will be very exciting for this company as they start sales to Hospitals, US DOD, Dept of Veterans Affairs, etc. imo
#SupDup


Summary: Long TSSI across short/near/long-term timeframes; plans to add heavily on further dips.

$TSSI - Bought at $11.75 - $11.95 for ST, NT & LT
Plan to add heavily if I saw any further dips
#SupDup


Summary: Bullish TRUG on IBM Watson AI partnership expected to enhance golf simulator/gaming products.

$TRUG - Recent partnership with $IBM Watson for #AI should make their Golf simulator and gaming products much superior. I will share more exciting details on this stock a little later today and tomorrow imo
#SupDup


I suggest to Elon Musk to BUYOUT Richtech Robotics Inc. at its dirt cheap valuation currently

Summary: Bullish RR: dirt-cheap <$80M valuation makes it a buyout candidate; disruptive AI humanoid robot applications.

$RR <$0.75 = <$80 mln valuation. I suggest to Elon Musk @elonmusk  to BUYOUT Richtech Robotics Inc. at its dirt cheap valuation currently. It makes #Disruptive #AI #Humanoid #Robots that have numerous applications in service industry imo
#SupDup @CathieDWood


I am loading up slowly because of thin float. I see it rising strongly in both NT & LT imo.

Summary: Actively buying HOUR at $1.45; expects strong near- and long-term price rise.

$HOUR $1.45 - Keep your 👀 on it.
I am loading up slowly because of thin float. Feel free to join me if you missed out on huge spikes in $RKLB $OPTT $AAOI $LUNR and others. I see it rising strongly in both NT & LT imo.
#SupDup @CathieDWood @wallstreetbets @nico_riera


Summary: Bullish SMCI; expects Bridgewater's position to generate quick, large gains.

@PeloSwing Bridgewater Associates going to mint a lot of money that too very quickly from their investment in $SMCI imo

The Largest Hedge Fund in the World by AUM just made some big changes to its portfolio 🚨

Bridgewater Associates sold 1.8M shares of $NVDA, but bought 437K+ shares of $PLTR and 1.45M+ shares of $SMCI in the third quarter 👀

What do you think of these moves? https://t.co/rsO1KK0soj


Summary: Long TRUG, bought in 2024 expecting huge profits by 2025.

$TRUG $0.65 - Buying in 2024 to sell in 2025 for HUGE profits imo
#SupDup


Summary: Adding to CING on dips for short-, near-, and long-term holding.

$CING ~$4.20 - I am adding more on dips for ST, NT & LT
#SupDup


Summary: Short ZENA on spike to $10–$12; fundamentals don't support valuation, capital raise risk imminent.

$ZENA $8.70 rn down 15+% in AHrs
#SupDup

https://t.co/CBMGPeEvI2

$ZENA - Spike to between $10 - $12 = Time to SELL SELL SELL and run. Current fundamentals don't support present valuation. Watchout for capital raise in ST.
I may start a short position in this one  on spike from $1.50 a few days ago imo
#SupDup


Summary: Long SMCI; buying dips near-term and long-term, targets $75+.

@Oranjadaaa Why would I run away? $SMCI I am still a firm believer and see the stock as buying opportunity on dips for NT & LT. I believe it will be back to $75+ someday, it will need patience imo

@SuperDuperInvst Dumping bags into SMCI or running away?


Summary: Bullish XAIR long-term; short attack seen as temporary, shorts will eventually cover.

$XAIR $0.45 - Unfortunately seems like short attack due to larger float and weak overall market today. Anyways this one is for investors with patience so if you don't want to hold for NT & LT you may want to get out now but eventually shorts will have to buy and cover sooner or later imo
#SupDup


Summary: Calls 100%+ upside on CING, ALLR, KPRX, and ANVS from current prices; buy-and-hold thesis citing cheap valuations.

$CING $4.20 $ALLR $1.05 $KPRX $3.40 $ANVS $6.25 - ALL will be UP 100+% from their today's dirt cheap prices & valuations. Time to buy and hold strongly like $AAOI buys from ~$8 and now ~$45 within 5 months imo
#SupDup @CathieDWood @BillAckman


Summary: Expects major news catalyst at CES (Jan 7-10 2025) to drive stock much higher from sub-$1.

$RR <$1 - CES is in Las Vegas between Jan 7th - Jan 10th, 2025
I expect HOT NEWS from the company around that time and stock be much much higher than you are seeing today imo
#SupDup


Summary: Bullish HOVR on $250M–$500M LOI with Indian operator JetSetGo for Cavorite X7 aircraft.

$HOVR - Interesting to see they have already lined up buyer in India that may place orders of $250 mln or possibly $500 mln imo.
#SupDup

Horizon Aircraft Enters into Letter of Intent to Purchase $250M of Cavorite X7 Aircraft, with an Option for up to $500M ~ HorizonAircraft Signs Letter ofIntent with JetSetGo,a LeadingRegionalAir TransportationOperator in India ~ TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- New Horizon Aircraft Ltd. (NASDAQ: HOVR), doing business as Horizon Aircraft ("Horizon Aircraft" or the "Company"), a leading hybrid electric Vertical TakeOff and Landing ("eVTOL") aircraft developer, announced today that it has entered into a Letter of Intent ("LOI") with JetSetGo, a regional air operator servicing multiple mission profiles. This LOI allows JetSetGo to purchase 50 Cavorite X7 Aircraft at a purchase price up to $5M USD per aircraft for a total aggregate consideration of $250M USD, with an option to purchase an additional 50 aircraft for a total possible consideration of $500M USD. Brandon Robinson, Chief Executive Officer of Horizon commented, "We are truly honoured by this commitment from JetSetGo, a leading private aviation operator with a shared vision of a more sustainable and efficient on-demand regional travel. We are confident that our Cavorite X7 eVTOL will operate sustainably and profitably across India as well as many other global locations. As a hybrid electric aircraft, there is no need to install expensive charging support equipment across the travel network; it is a machine designed for challenging, real-world operations." Kanika Tekriwal, JetSetGo's CEO and co-founder, stated, "Our decision to enter into this Agreement with Horizon Aircraft was not taken lightly. We ultimately decided to partner with a company with a deep operational and aerospace technology background that will deliver a product that will help usher in a new era of sustainable air travel while also providing significant value for our customers. This partnership will help JetSetGo profitably enter new markets by leveraging the versatility of the Cavorite platform to bring about the vision of Advanced Air Mobility in India."


Summary: Bullish RR over 2-3 years as products develop and service robots deploy across airports, hospitals, malls and more.

$RR - They have not, they are still developing their products. Give them like 2-3 yrs. I believe it will be very different. Should emerge as a big player in the industry.
Service robots will be seen at so many places from Airports to Sea Ports to Restaurants to Bars to Casinos to Malls to Hospitals...... Everywhere imo

@sistersib @SuperDuperInvst No, $RR missed the chance to capitalize on the exposure from $SERV’s run


Summary: Long SOBR: undervalued with short-squeeze potential; bullish across short, near, and long term.

$SOBR - Once the penny flippers are gone it will get very interesting. I expect MM here to get trapped just like how I had mentioned about $LITM when it was $0.17
Massive short squeeze could trigger huge rally but irrespective of all of it stock is undervalued currently and is a good buy for ST, NT & LT imo
#SupDup


Summary: PLTR is overvalued at $76+; bearish valuation verdict.

@TrillzMMA No not at $PLTR but it is OVERVALUED too at $76+ imo

@SuperDuperInvst Is this aimed to palantir? Because amc and palantir are 2 completely different companies


Summary: Still bullish RR toward $3–$5 target after 100%+ gain; expects continued upside through 2025.

$RR ~$1.60 rn already UP 100+% quickly since I first showed you here recently.
Gonna get there   👇   slowly & steadily imo    🤑  💰
#SupDup

https://t.co/u3OSGRWEgk

$RR $0.75 - $0.80 - Will be $3 - $5++++ in 2025
Start loading up if you have vision and some patience imo.
#SupDup


Summary: Long ANVS at $7.10; loading up short/near/long-term on promising late-stage AD & PD trials, benefiting from SAVA's drug failure.

$ANVS $7.10 = Good BUY given $SAVA Cassava Sciences' #Alzheimer Disease drug (AD) failed.
Annovis Biosciences late stage clinical trials show very promising results for their AD & #Parkinsons Disease (PD) drugs imo as such I am loading up for ST, NT & LT imo
#SupDup


Summary: Price target $25+ for KSCP in both near-term and long-term.

industry='Security & Protection Services'

@SuperDuperInvst Do we have a PT in mind and timeline for KSCP?


Summary: Bullish on TRUG's new franchise golf/entertainment concept as a driver of future revenues and profits.

$TRUG - This new concept that mgmt recently rolled out will be HUGE & great source of added revenues + profits in the future once this concept grows as franchise model to #GOLF, eat & drink year round without worrying about hot or cold weather all while having entertainment with others imo
#SupDup


Summary: Long EDBL multi-year on organic/health-food demand wave, new vitamin product launches, and expected strongest quarter in company history.

$EDBL - Volume and price rising  !!
Healthy #Organic farm fresh produce =  new wave as Americans try to stay healthy & fit. Company's products are in great demand and like I mentioned before I expect this to be STRONGEST qtr in history of company as they have launched variety of new Vitamin products lately.
Buy and hold for a few years and this could be a huge jackpot  imo  🤑  💰
#SupDup


Summary: Bullish SMCI to $50+ near-term, $75–$100 by 2025 on anticipated analyst upgrades.

$SMCI - Next will be several analysts upgrading the stock and it will be back to $50+ and may even see $75 - $100 in 2025 imo
#SupDup


Summary: Conditional bullish call: if BTC hits $100k, MSTR reverses higher.

@TheBTCTherapist IF #Bitcoin rises to $100k or higher = $MSTR U turn imo

If you know what’s happening with MSTR right now you already understand we’re hitting $100,000 #Bitcoin tonight. https://t.co/ZkbiU9aAXy


Summary: Author urges SoundHound to acquire Richtech Robots at $250M, citing strong strategic synergies between robotics and AI voice commands.

$SOUN should pay $250 mln and BUYOUT $RR.
@SoundHound use your inflated stock price as currency and grab @RichtechRobots while it is baby.  I see tremendous strategic synergies between the two companies. Would prove to be great acquisition in future when combination of Robots and AI driven commands integrate imo
#SupDup

https://t.co/1yVqZ6AMyS


grab @RichtechRobots while it is baby. I see tremendous strategic synergies between the two companies


Summary: Bullish on ALLR under $1.25; expects it to take off at some point.

$ALLR <$1.25 - Mark my words, 1 day this will  takeoff 🔥  🚀  imo
#SupDup @wallstreetbets


Summary: Bullish QUBT and LAES as quantum computing chip plays; QUBT up 125%+ today with more implied upside.

$QUBT - UP 125+ % so far today, Its Quantum Computing  chip play just like $LAES imo
#SupDup


Its Quantum Computing chip play just like $LAES imo


Summary: Adding to KSCP position; expects strong gap up today.

Good morning America !   🇺🇸
$KSCP $11.25 - Keep your   👀  on it. I will be adding more. I hope it opens flat or lower but I expect a STRONG GAP UP today imo
#SupDup


Summary: Shares/endorses Needham Buy initiation on DECK with $218 PT.

$DECK $183+ rn  🤑 - Deckers Outdoor initiated at Buy, Price Target Announced at $218.00/Share by Needham
#SupDup #FastMoney

https://t.co/6gaVJ6VrAT

$DECK < $155 - Good opportunity to buy for ST & NT imo
#SupDup #Hoka #Deckers


Summary: Disclosed long position in AIMD, bought at $0.60–$0.72 for short, near, and long-term holds.

$AIMD - Bought between $0.60 - 0.72 for ST, NT & LT
#SupDup


Summary: Buying MSTR on dips below $353 for short/near-term trade.

$MSTR - Starting to Buy <$353 on dips for ST/NT
#SupDup


Summary: Add OPTT on dips; avoid NVDA as dead/stagnant; prefer RR which is on a run.

@DarthCaper $OPTT $0.28 - may drift somewhat lower but it will be good opportunity to add more on dips for ST, NT & LT.
$NVDA is dead/stagnant lately, I would rather be in a stock that is on run even if it is penny stock like $RR imo

@SuperDuperInvst How do you see OPTT and what are your thoughts on Nvidia having a rough week? TIA!!


Summary: Long TSSI from ~$11.30 to $25+ by end of 2025.

@XTraderTrader Yes $TSSI $11.30 should rise to $25+ in 2025 imo
#SupDup

@SuperDuperInvst $TSSI float is getting more locked up here, just needs a little more volume to go to $15-20


Summary: Long Richtech Robotics with near-term PT $1.50–$5 and long-term PT $5+++ on AI-driven humanoid robot thesis.

🚨  New Super Duper Stock Pick  🚨
$RR <$0.75 - Richtech Robotics Inc. maker of #Disruptive #AI driven #Humanoid #Robots.
My NT PT is $1.50 - $5, LT PT is $5+++ imo
Will share more info later but check this video out where Adam their robot bartender made & served $NVDA CEO a drink   🍸  👇
#SupDup @CathieDWood @wallstreetbets

https://t.co/en7lq3QL1S


Summary: Actively accumulating ALLR today.

$ALLR - I am accumulating today.
#SupDup


I feel in NT & LT it could be seen at $1+ given they are on a decent growth track... I expect sales to rise sharply this qtr and going forward. I am still holding a large quantity for ST, NT & LT imo

Summary: Long EDBL targeting $1+ on 324% gross profit surge, expects sharp sales growth in Q4 and into 2025; holding large position.

$EDBL <$0.22 - Is a penny stock but not a penny junk. I feel in NT & LT it could be seen at $1+ given they are on a decent growth track as seen from gross profit for the first nine months of 2024 surged by $1.7 million an impressive 324% increase over the prior year. I expect sales to rise sharply this qtr and going forward. Remember this used to be $10+ stock earlier this year.
2025 could be a game changer for the company. I am still holding a large quantity for ST, NT & LT imo
#SupDup


Summary: Bullish KSCP from ~$12 to $20–$30 this year.

$KSCP ~$12 - Slowly marching towards teens, should see between $20 - $30 this year imo
#SupDup


Summary: Strong buy on HOUR at $1.50; expects 50–150% gain within 3 months with minimal downside risk.

$HOUR $1.50 - Start loading up if you have patience to hold for 3 months. Within 3 months it will rise 50% to 150%.
Downward risk is none to very little imo.
#SupDup


Summary: Adding to a large long position in LAES on dips; bullish on its multi-sector quantum computing exposure.

$LAES $0.43 - I am adding more on dips building a large long position.  Compare it with recently spiked $QUBT $2.75
Both Quantum Computing Chips plays But SealSQ has presence and product offerings in many more hot sectors imo.
#SupDup


Summary: Expects a short squeeze in SOBR within the next 10 days.

$SOBR - We could see short squeeze within next 10 days imo
#SupDup


Summary: Bullish SOBR: expects stock to surge in 2025 despite criticizing management's missed retail distribution opportunities.

$SOBR $1.10 - If I was on ELT of the co, I would have made sure that company's product 'Real Time Alcohol Detection Wristband' was made available for purchases at Amazon, Walmart, CVS, Target & other etailers/retailers during holidays and in time for New Year parties. I would have already lined up few marketing deals and put out PR about it to get the word out and to get sales boost.
But I still believe stock will not remain Sober and get wild in 2025 imo.
#SupDup


Summary: Bearish SERV; current price overvalued, targets below $16.20 based on weak fundamentals and uncertain delivery concept.

$SERV <$16.20  🤑
#SupDup

https://t.co/B2bG9HKyZK

$SERV $21.25+ rn = OVERVALUED based on its today's fundamentals, sales growth & profit prospects. Its robotic last mile food delivery concept may even fail in USA given ...... I don't want to say it why but some of you smart folks can figure it !
I would stay clear until there is


Summary: Intel below $22.75 is a golden long-term buying opportunity.

$INTC <$22.75 = GOLDEN BUYING OPPORTUNITY for LT investors imo
#SupDup #Intel $NVDA $SMCI $AMD $DELL $HPQ


Summary: Bullish SOBR; expects market makers and short sellers to get squeezed.

$SOBR - MM & Short Sellers are gonna get trapped here again imo
#SupDup


Summary: Bullish XAIR as dirt-cheap M&A target with huge upside; compares to PLTR's multi-year sleeper-to-darling trajectory.

$XAIR - Prime takeover candidate for a large medical devices company to expand or diversify their product range given the current value is dirt cheap and the future potential is HUGE. This is a stock that may be like $PLTR that sat for years <$10 with no one cared and suddenly it has become wall street darling in AI imo
#SupDup


Summary: Long both ALLR and KPRX; added to both today, bullish near- and long-term, prefers KPRX as safer choice.

@eeb_si I own both $ALLR and $KPRX. Am very bullish on their NT & LT prospects. Added more both of them today but I think safer choice would be Kiora Pharma if you have patience imo


Summary: Views dip as healthy pullback; expects significant jump later this year, great story after Q3.

$RR $3.55 - After 600+% rise there is some profit taking I guess. It could be because we didn't hear of any new product launch or large customer announcement at CES so far. I see this as healthy pullback, it will jump significantly one day this year. I have said it this will be great story after 3 qtr of this year imo
#SupDup

@SuperDuperInvst What’s your take on the RR crash and general news surrounding it ?


Summary: Predicts RR moves from $0.75 to $2–$3 next.

$LAES $0.37 to $1.99 UP 450%
$WKEY $2.10 to $8.75 UP 300+%
Both jumped up very fast recently since I mentioned those.
Next gonna be $RR $0.75 to $2 - $3 imo
#SupDup


Summary: Bullish on KPRX, ALLR, ANVS, CING ahead of expected positive clinical trial results or licensing deals; expects rocket-like moves.

$TEVA Teva Pharma and $SNY Sanofi both added BILLIONS of dollars in value today from the news of successful phase 2 clinical trials for their GI tract related Ulcerative Colitis & Chron's diseases drug.
Now imagine what could happen to $KPRX $ALLR $ANVS $CING when they will announce positive outcomes of their respective clinical trials and/or licensing deals. They will takeoff like    🚀  🚀  🚀  imo
#SupDup

https://t.co/0bEvqKgi98


Summary: Bullish SMCI; decisive quality verdict that business is firing on all cylinders.

$SMCI - Firing on all cylinders imo
#SupDup


Summary: Raising near-term price target on SMCI to $52–$66 from current $41.50.

$SMCI $41.50 - Raising my NT PT to $52 - $66
#SupDup


Summary: Expects a massive short squeeze in ALLR with sellers drying up and buyers stacking on L2.

$ALLR - I smell massive short squeeze coming, do you? Sellers are drying. Long line of buyers seen on L2.
Would love to see $DRUG $ATNF style spike imo.
#SupDup


Summary: Infers Saylor's continued BTC purchases at ATH imply he expects price to go much higher.

@DjLiLwHiT $MSTR - I am not an expert on #Bitcoin but given Michael Saylor keeps buying more & more even at current all time high prices, he must be thinking it is heading much higher imo.

@SuperDuperInvst Do you have an opinion on $MSTR asset accumulation of BTC, even buying at all time highs?


SCREAMING BUY for NT but mostly LT investors... This stock is a MUST BUY for investors with 2 to 3 yrs patience and investment horizon imo

Summary: Strong long INTC under $21 on AI chip contracts, AI device demand wave, and US defense orders over 2–3 year horizon.

$INTC <$21 - SCREAMING BUY for NT but mostly LT investors. Will be soon most likely start making #AI chips for $AMZN and others per their designs. New wave of AI Desktops, Laptops & Tablets will create a huge new demand in next 1 to 2 yrs. Expect large US govt orders for defense sector chips in next 1 to 2 yrs.
This stock is a MUST BUY for investors with 2 to 3 yrs patience and investment horizon imo.
#SupDup


Summary: Expects ALLR to close between $1.50–$1.75 (from $1.25) on high volume if market turns green.

$ALLR $1.25 - I expect 1 mln or higher trading volume today with close between $1.50 - $1.75 if the market turns green imo
#SupDup


Summary: Bullish RR to $10+ on potential McDonald's robot deployment order, even a small 100-unit initial order.

$RR $2.95 - McDonald's 1st order announcement whenever (IF they decide to deploy 1 robot at each location) or even a small order for just 100 robots to start with can send this stock to $10++++ imo
This is so cool !!! Anyone near the McD in Dallas or San Diego please visit this weekend and get a better video for all of us.
#SupDup

https://t.co/ilq3su2WtB


Summary: Holds EDBL long, not worried by price drop, committed for near- and long-term.

@GburyStrength I haven't had a chance to look at the news but see the price drop. I own and am not worried as I am in for NT & LT imo

@SuperDuperInvst $EDBL had news yesterday and today. Are you still buying and thoughts for NT/LT?


Summary: RR is undervalued at $1.30 and should be $5 or higher; bullish.

$SERV $17.25+ rn   😍
$RR $1.30 should be $5 rn or higher comparatively imo
#SupDup


Summary: Adding to long position in AIMD at $0.60–$0.62 for short-, near-, and long-term.

$AIMD - Adding more at $0.60 - $0.62 for ST, NT & LT
#SupDup


Summary: Bullish OPTT on military contract via RCAT partnership, 71% backlog growth, and record $92M pipeline.

$OPTT $0.155 - Future prospects look great because of their strategic deal with $RCAT which recently secured a large US Military contract and for several other reasons including  👇
Backlog: $5.3 million, a 71% increase compared to the prior year.
Pipeline: Approximately $92 million, the largest in the company's history.
#SupDup


Summary: Still holding a large position in Rolls-Royce.


Summary: Conditional long RR: a large McDonald's order could send the stock to $10 from $2.90.

$RR $2.90 - Richtech Robotics service robot seen serving at a McDonald's restaurant in California (click link below to see the video). Yes this is different location than the past one I shared which was from Dallas, TX.
IF they get a large order from $MCD the stock could suddenly jump to $10 upon the pr imo    😍
#SupDup

https://t.co/4Gwz80nePu


Summary: Bullish RR to $10 in 2025; longer-term sees potential for $100.

I may sound like Cathie Wood but $RR $3 may someday be way higher like $100 stock   😂  on a serious note $10 is very possible in 2025 imo
#SupDup


Summary: Strong short call on DRUG; expects heavy decline from $57.70+.

$DRUG <$37 rn
#SupDup

https://t.co/rOZyfH1Ist

$DRUG $57.70+ rn = SELL SELL SELL, Short Sell it will tank heavily imo
#SupDup


Summary: Still holding large RR position and adding on dips; expects real sales boost in Q2/Q3 driven by a major customer order like McDonald's.

I have seen the 10k and yes it is not good because they have changed their sales model but I had mentioned b4 that don't expect anything exciting when they report. Real sales boost will start after 2nd or 3rd qtr of this year. This is going to be HUGE as soon as one big name company like McDonald's place an order. I am still holding a lot and plan to add more on dips for ST, NT & LT investment imo

@SuperDuperInvst @danzi05 Are you adding to $RR or are you worried about the 10K


Summary: Long ALLR with $2–$5 price target this year, despite expected volatility.

$ALLR - Went to $1.70+ today, Almost UP ~100% as I had mentioned one day it will   🚀    🤑    💰
Told you all patience will pay off, I see it rising to between $2 - $5 this year with many ups & downs imo
#SupDup

https://t.co/uCn540LruQ

$ALLR $0.90 - Slowly doubling my holding to cost avg. Float is thin at <1.5 mln shares. Trading at 1/4th of cash on hand value currently. Advancing promising anti #Cancer drugs discovery pipeline with Ovarian cancer trials in advance phase 2 stage & now icing on cake is its #Gene


Summary: Buying ALLR at ~$0.90 targeting $2–$5 on Phase 2 anti-cancer drug clinical benefits.

$ALLR ~$0.90 - I am buying today. One good news and this could spike to $2 - $5 very easily.
Valuable & Promising asset in Phase 2 trials Anti cancer drug Stenoparib showed clear clinical benefits, including TUMOR SHRINKAGE and long-term disease stability, in heavily pre-treated Ovarian cancer patients imo.

https://t.co/VM8e5lXQIk


Summary: HOUR should rise from $1.45 to $2–$4 within 3 months.

@bbsjbf $HOUR $1.45 - Should rise to between $2 - $4 within 3 months imo
#SupDup


Summary: Bullish HOUR: $200M+ 2024 sales on strong holiday season; $60M mkt cap looks cheap vs guidance range of $165-250M.

$HOUR - Current mkt cap $60 mln. Only 1.6 mln shares in float with 95% holding of outstanding by few of its insiders. Been in bed with $AMZN #Amazon for years since they are their key trading partner other than $WMT #Walmart & $ETSY.
2024 projected sales are going to be between $165 mln to $250 mln.
I would expect them to have at least $200 mln in sales in 2024 given this holidays season will be one of the STRONGEST for etailers and retailers imo
#SupDup


Summary: Still holding RR with targets $2–$5; cites LAES 1000% run as analogy for staying patient.

$RR hit $1.40 but I have still NOT sold a single share. I want it to rise slowly & steadily to $2 - $3 - $5....
Just ask those that sold $LAES at $0.40 - $0.45 - $0.50 $0.60 - $0.75 or even at $1 because days later it jumped to ~$3.50 rising 1000% so quickly since I showed at $0.37 recently imo
#SupDup


it jumped to ~$3.50 rising 1000% so quickly since I showed at $0.37 recently


Summary: Still bullish on EJH at $0.70–$0.75 despite 25%+ intraday spike.

🚨  Okay guys so that stock I almost finished my DD and was planning to show as my new Super Duper pick is $EJH which was ~$0.65 last week and earlier today but suddenly in last hr or so it jumped 25+% to ~$0.80 before I got chance to finish all my DD and share its details with you all.
I still like it at $0.70 - $0.75 imo
Later I will share more info on what I have learnt during my DD.
#SupDup


Summary: Long SMCI from ~$32, targets $40s–$50s within 45 days.

@theresa_perrin $SMCI $32 - Should rise to $40's or even $50's within 45 days imo

$SMCI is up in the after hours and the daily chart looks like a break out is coming.


Summary: Long TSSI to $50+ long-term; bullish ST/NT/LT on data center, networking & AI exposure with strong quarterly ER.

$TSSI <$11.50 - In LT this can be even $50+ stock. Its a data center, networking & AI related play in fast growing hot sector with huge demand.
Just glance through their last quarterly ER and you will see why I am so bullish on its ST, NT & LT prospects imo
#SupDup

https://t.co/z8JycjeOnj


Summary: Bullish SMCI; disputes claim it lost business to Dell, asserting NVDA/AMD/INTC/TSLA remain long-term clients on AI cluster demand.

Lol NOT true at all. $NVDA $AMD $INTC $TSLA #X are in bed along with many other leading companies that rely on Super Micro #AI cluster servers that are extremely powerful & cost efficient due to their unique cooling technology and configurations.  All of them will remain as clients / strategic partners for a LONG TIME riding this AI demand wave imo

@SuperDuperInvst We are pretty sure $SMCI already lost all this business to $DELL.

Discussed on @WOLF_Financial  spaces today with @PipelineDataLLC


Summary: Loading up on SOBR ahead of expected positive catalyst within 10 business days.

$SOBR $1 - ⚡⚡⚡
I am loading up.
Keep your  👀 it, Next week will be exciting, expecting some good news within next 10 business days imo  🤑
#SupDup


Summary: Adding to RR, AIMD, and TSSI on dips across short, near, and long-term timeframes.

$RR, $AIMD & $TSSI - Adding more on dips rn for ST, NT & LT
#SupDup


Summary: Loading up ALLR under $1.25 and KPRX under $3.30, expecting much higher prices on future good news.

$ALLR <$1.25 & $KPRX <$3.30 - Not many interested in buying rn so I am going to load up cheaply to sell some day when there is good news and everyone chases at much higher prices to buy buy buy.
Buy low sell HIGH = JACKPOT  🤑  💰  imo
#SupDup


Summary: Expects a strong gap up in RR tomorrow.

$RR - STRONG GAP UP tomorrow imo
#SupDup


Summary: Expecting positive news catalyst for TRUG within 10 days.

$TRUG - Keep your 👀 on it, within next 10 days I am expecting to hear some good news imo
#SupDup


Summary: SMCI will outperform NVDA and AMD in 2025, rising the most among the three.

@MomAngtrades $SMCI will rise the most amongst the 3 you mentioned imo

$NVDA $AMD and $SMCI won’t be the hot stocks in 2025….


Summary: Suggests ATLX management acquire dirt-cheap LITM (~$5M mkt cap); implicit bullish lean on both names.

industry='Other Industrial Metals & Mining'

Lithium exploration company $ATLX $8.20 up ~25% within a week. I suggest to their management @Atlas_Lithium should consider buying out Snow Lake Energy $LITM $0.17 (dirt cheap ~$5 mln market cap rn) that have been exploring both #Lithium and #Uranium imo
#SupDup https://t.co/nYE9a7gFP1


Summary: Accumulating LAES below $0.45 for short-, near-, and long-term holds.

$LAES <$0.45 - Accumulating for ST, NT & LT
#SupDup


My NT PT is $1 - $3 and LT PT is $5+ imo. Please do your own in depth research and if you like it join me in buying.

Summary: Long AIMD from ~$0.55 with NT target $1–$3 and LT target $5+ on AI Nose disruptive platform; sub-$8M market cap seen as major opportunity.

🚨   New Super Duper stock pick   🚨
$AIMD ~$0.55 - Ainos, Inc. is a working on #Disruptive #AI Nose technology platform for the robots to be able to detect smell. This could be HUGE opportunity as they seem to be way ahead in the game.
Current mkt cap is less than $8 mln. I feel this could be great NT & LT investment for investors with patience & vision.
My NT PT is $1 - $3 and LT PT is $5+ imo
Please do your own in depth research and if you like it join me in buying.

Ainos is a diversified healthcare company focused on novel AI-powered point-of-care testing (POCT) and low-dose interferon therapeutics (VELDONA®). The Company's clinical-stage product pipeline includes VELDONA® human and animal oral therapeutics, human orphan drugs, and telehealth-friendly POCT solutions powered by its AI Nose technology platform.
#SupDup


Summary: Bullish LAES at $0.38; expects potential skyrocket on 2 new quantum chips launching this quarter, stock previously ~$4.

$LAES  $0.38 👇 Can it skyrocket like $QUBT ? Yes that's possible given the stock used to be ~$4 not long ago and given its going to launch 2 new Quantum Computing chips this qtr imo
#SupDup @ACInvestorBlog

$LAES is a quantum computing name like $QUBT Check this out https://t.co/ea4iwCtGHj


Summary: Holding and adding to KSCP; expects multi-bagger returns in near and long term.

$KSCP - I have NOT sold a single share today despite its spike to $12.25+ earlier.
Slowly I keep adding more & more.
With patience I believe this one will turn out to be a Multi Bagger providing opportunity to make a LOT OF MONEY in NT & LT imo
#SupDup #Disruptive #AI #Safety #Security #Robot


Summary: Expects ALLR to jump once class action lawsuit is resolved; views it as an overhang from prior management.

@JoshuaEpstein86 Its an old issue lingering from prior management. Current mgmt has said it is baseless. I expect co will be pay some fines without admitting any wrong doings. Once that gets cleared up it would jump up imo

@SuperDuperInvst What’s your opinion on the ALLR class action lawsuit?


Summary: Long MBIO; holds a position and expects it to eventually pay off.

@jackpot2200 I own many, it will have its day imo

@SuperDuperInvst $mbio is trying to freak us out . I am long for it


Summary: Buying TSSI under $11.50, targeting $25+ by end of 2025.

$TSSI <$11.50 - I am buying as I see stock rising to 25+ in 2025 imo
#SupDup


Summary: Author is actively adding to CING position for short, near, and long term.

$CING $4 - Remember  👇 Click and see why I am loading up more & more for ST, NT & LT imo.
#SupDup

https://t.co/PUsiVbqabB

$CING $4.50 - Current market value is <$15 mln, whereas Cash on Hand is $10+ mln. HUGE potential with its late stage pipeline of #ADHD & #Anxiety drugs under developement and more with PTR platform.
One fine morning we could see it suddenly spike 100%, Great buy for NT & LT https://t.co/4hY0T4j7DG


Summary: Strongly bullish KPRX near $3.55; author cites Goldman accumulation, analyst Buy ratings ($27–$54 PT), cash runway into 2027, and tiny float.

Recent followers, Click below link to see why I am so bullish on both NT & LT prospects of $KPRX $3.55 that even Goldman Sachs picked up a large chunk at $3.66 avg imo
#SupDup

https://t.co/5F1OHsV4CD

$KPRX $3.50 - GOLDEN BUYING OPPORTUNITY for LT investors. Read below to see why I say so.
Current Value: ~$10 mln, 3x Cash on hand of ~$30 mln (Expected runway into 2027)
Equity float: 1.36 mln shares

Buy rating with $54 PT by Ladenburg Thalmann
Buy rating with $27 PT by Maxim


Summary: Still long ALLR with large position and plans to add more.

@shumbro $ALLR will have its day. I still hold a lot and plan on loading up even more at some point imo

@SuperDuperInvst I appreciate your expertise and followed some recommendations, but so far I didn’t make any profit unfortunately. Once I do, happy to start paying :) still sitting on  $ALLR 🤞


I own a large qty... IF one day they report encouraging results or licensing deal, stock will look cheap even at $2 imo

Summary: Holds large position in MBIO; sees stock as cheap even at $2 on potential positive results or licensing deal.

@NickFrancone23 @27macneil $MBIO $0.20 - I own a large qty, just like any penny stock and cash strapped companies it is risky but no pain no gain. IF one day they report encouraging results or licensing deal, stock will look cheap even at $2 imo
#SupDup

@SuperDuperInvst @27macneil Thoughts on $MBIO?


Summary: Actively buying ALLR on dips at $1.20–$1.30, primarily as a long-term position.

$ALLR - Added and adding more on dips between $1.20 - $1.30 for NT but mostly LT imo
#SupDup


$TPL $1700+ = SELL SELL SELL, Lock your profits on this massive spike. Be careful chasing it here imo

Summary: Sell TPL at $1700+; author warns against chasing the spike after following it since sub-$500.

$TPL $1700+ = SELL SELL SELL, Lock your profits on this massive spike. I have been following this company for years since its stock was <$500.
Be careful chasing it here imo
#SupDup


Summary: Long RR across short, near, and long-term timeframes; adding on dips; bullish on potential large service-robot orders.

$RR - I agree @Mitch___Picks   👇
Holding tight and adding more on dips for ST, NT & LT. I will be excited and thrilled the day we hear news of a large global company like #McDonalds or #Starbucks placing a large order for service robots from this company imo
#SupDup

$RR swing looking very strong pre market. Through resistance, next stop 1.25-1.50+


Summary: Long RR from ~$0.85 targeting $1–$7 in 2025; recommends loading up for short-, near-, and long-term.

Missed out on several of my 100% to 1000% quick gainers? Don't worry I will be sharing many more such picks down the road. Here's one for now.

$RR ~$0.85 - Will be seen between $1 - $7 in 2025
Check it out quickly, IF you like what you see and believe in my start LOADING UP for ST, NT  but mostly LT imo
#SupDup


One day in 2025 we will hear huge good news which could send stock to $5+ … this is a great buy on dips and for investors with vision and patience

Summary: Long RR to $5+ on expected 2025 catalyst; meaningful sales boost from Q3, buy on dips despite near-term earnings disappointments.

$RR $2.45 - One day in 2025 we will hear huge good news which could send stock to $5+
Earnings report for last qtr, present qtr and next qtr will be disappointing which I have mentioned before. Meaningful sales boost will be seen starting 3rd qtr of this year which is why I say this is a great buy on dips and for investors with vision and patience imo
#SupDup


Summary: Building a large long position in LAES for both near-term and long-term.

$LAES  - Read this   👇 1 of many reasons I am building a large long position for NT & LT imo
#SupDup

https://t.co/54VYdpmUCb


Summary: Long KSCP at $11 with NT PT $15–$30 and LT PT $40+; AI robotics/public safety play with short-squeeze potential on low float.

🚨   New Super Duper Stock Pick   🚨
$KSCP $11 - Knightscope Inc. an #AI powered #Disruptive #Robotics play in Public #Safety.
Clients includes US Govt agencies, Police, Hospitals, Casino, Hotels, Universities, Malls, etc.
Low float of <2.7 mln shares with $20+ mln cash on hand. Rising sales. No toxic warrants, heavily short sold which could trigger squeeze upon any big contract or other good news. 52 week high of $32.
Huge $40 bln market opportunity per mgmt.

IF the mgmt plays their cards right and capitalize on the huge opportunity with global sales, this could emerge as a dominant player in Security & Crime Prevention sector both of which are in great need & demand.
Feels like a mini $AXON ($45 bln co today) like 10 yrs ago when its stock was trading in teens when it used to be Taser International.

Please do your indepth DD and if you like it, join me in buying for ST, NT but mostly LT.
My conservative NT PT is $15 - $30, LT PT is $40+ imo
#SupDup


OVERVALUED based on its today's fundamentals, sales growth & profit prospects. I would stay clear until there is more color... Many reasons why I may even may consider opening a short position upon any further spikes

Summary: Bearish SERV at $21.25+: overvalued on fundamentals, weak sales/profit prospects, concept may fail; would avoid and may short on spikes.

$SERV $21.25+ rn = OVERVALUED based on its today's fundamentals, sales growth & profit prospects. Its robotic last mile food delivery concept may even fail in USA given ...... I don't want to say it why but some of you smart folks can figure it !
I would stay clear until there is more color that we can see which may take a few years still. Many reasons why I may even may consider opening a short position upon any further spikes imo.
#SupDup


Summary: Adding to long position in TRUG across short, near, and long-term timeframes.

$TRUG $0.73 - Adding more for ST, NT & LT
#SupDup


Summary: Long RR to $10+ within a year, catalysts being a large contract from McDonald's or Starbucks.

$RR - $5.40 this morning, Didn't I say it?  It happened. Now I am saying stock with many ups & downs will be seen at 10+ within 1 year. Potential catalysts will be IF & When they get a decent size contract from McDonald's $MCD or some other large company like Starbucks $SBUX imo
#SupDup

https://t.co/xj7sSznGxf


PRIME TAKEOVER CANDIDATE. Company's ~$85 mln current market value is a joke and makes it extremely attractive for larger pharma companies wanting to expand or diverse their product offerings

Summary: Long ANVS under $6 as a prime buyout target for large pharma; ~$85M market cap seen as deeply undervalued vs licensing deal comps.

$ANVS <$6 ⚡⚡⚡
PRIME TAKEOVER CANDIDATE. Why pay $1 bln to $3 bln in licensing deals like the recent one you see in link below when you can BUYOUT a company with MULTIPLE drugs for #Alzheimer #Parkinsons #Dimentia #Stroke #Anxiety, etc. in mid to late stages.
Company's ~$85 mln current market value is a joke and makes it extremely attractive for larger pharma companies wanting to expand or diverse their product offerings imo.
#SupDup @CathieDWood @BillAckman @wallstreetbets @pfizer @Novartis @Merck @Roche @tevapharm @drreddys @Cipla_Global @SunPharma_US

https://t.co/WFsuev3RHP


Summary: Buying TSLA dips for a short-term trade around $420.

$TSLA - What's going on? I sold few earlier at $455+ the ones bought yesterday at $430 but now its down to $420  😍
Is it because of fears that EM will be getting too busy in Trump admin which may hurt Tesla since his focus will be not solely on company?
Anyone know the reason of selloff?  I am picking up some on dips for ST.
#SupDup


Summary: Long RR at $3, holding 5+ years, analogizing to missed TSLA/AAPL multi-baggers.

I sold $TSLA at $25 - $65 and thereafter it went to $4000+ split adjusted. I traded at many prices and still do but if I had held on to my original purchases think how big of a jackpot it could have been over the years. Same with $AAPL that I sold so many years ago at just $55   😭
NOT gonna make the same mistake with this one. Gonna put aside a chunk of $RR $3 and forget for 5 yrs or longer imo
#SupDup


Summary: Endorses TRUG breaking $0.8531 resistance; bullish on upside breakout.

@TigerLineTrades It will happen just matter of time imo

$TRUG NEEDS $0.8531 BREAK https://t.co/WQy3PKiJri


Summary: Considering adding more TRUG on dips below $0.60.

$TRUG <$0.60 - Trump is a TruGolfer may be its time for me to add more of this Golf stock on dips imo
#SupDup


Time for me to LOAD UP some in my IRA account and forget for 2 yrs ... stock could be as high as $40 - $55 imo

Summary: Loading up INTC under $21.35 in IRA; targets $40–$55 in 2 years on company transformation thesis.

$INTC <$21.35 - Time for me to LOAD UP some in my IRA account and forget for 2 yrs but I know its hard given I have to see my holdings often.
No matter who says what #Intel will be a very different company in 2 yrs and stock could be as high as $40 - $55 imo
#SupDup


Summary: Bullish ALLR; expects it will eventually move up, advises patience.

@Joffre37573863 It will have its day have patience imo


It will rise slowly & steadily with many ups & downs. I have a strong feeling that we gonna hear series of good news in next qtr starting with big news around CES in Jan 2025

Summary: Bullish RR at $1.25; expects slow steady rise with catalysts including big news at CES Jan 2025.

$RR $1.25 - It will rise slowly & steadily with many ups & downs. Actually such rise will be more healthier for NT & LT.
I have a strong feeling that we gonna hear series of good news in next qtr starting with big news around CES in Jan 2025 imo
#SupDup


Summary: LAES expected to reach $1–$5 on new chip sales, avoiding reverse split.

$LAES $0.37 - They have till Jan'25 to meet $1 so if they get stock trading for 10 days above $1 they won't need a RS. Also even past Jan'25 they can appeal and get 180 days extension which should be ample time till they start sales of their new chips which should bring the stock price to $1 - $5 imo.
#SupDup

@SuperDuperInvst Any possibility of an RS for LAES?


Summary: Buy AIMD under $0.70 as a near-term and long-term play for patient investors.

$AIMD <$0.70 - LOAD & LOCK only if you have vision and patience, Gr8 NT & LT buy imo
#SupDup #Disruptive #AI #Nose #Robot


Summary: Bullish EJH on extreme undervaluation: $7M market cap vs $100M cash and $50M+ sales.

$EJH $0.80 - From what I see unless I am missing something. And yes I know it is Chinese company.
Sales $50+ mln last year
Cash on hand $100 mln
Current Mkt cap $7 mln
Gross Profit $12.7+ mln

The company is mainly involved in:
1. Home appliances, smart home installation, maintenance;
2. Housekeeping, nannies, maternity matron and cleaning services;
3. Internet aging + home care;
4. Units of public places cleaning.
After years of development, E-Home has formed two main business channels, ToB and ToC, with two important subsidiaries.

Two main channel:
1. The ToC business to nanny, maternity matron, home care, cleaning, repair, maintenance of family integrated services.
2. The ToB business to public cleaning.
Two subsidiaries:
1. Zhongrun Pharmaceutical, integrating pharmaceutical warehousing, distribution, wholesaling, retailing, and online sales;
2. Chuangying: presidential training, internal training, corporate consulting and counseling, and policy counseling. E-Home has been a comprehensive service enterprise for family life! We have always adhered to the "solving every issue of customers with heart" business philosophy, adhere to do the industry benchmark.
#SupDup


Summary: Adding heavily to EDBL; targets $1–$2.75 by 2025.

$EDBL $0.33 - Adding heavily as I see it slowly rising to between  $1 to $2.75 in 2025 imo
#SupDup


$ANVS <$6.50 - LOAD LOAD LOAD up time for me. It can be tomorrow's MONSTER pharma company

Summary: Strong buy on ANVS under $6.50, citing rich drug pipeline and potential to be a monster pharma company.

$ANVS <$6.50 - LOAD LOAD LOAD up time for me. Check it out folks. It can be tomorrow's MONSTER pharma company. I remember $JAZZ trading stagnantly at $5 and thereafter it went to as high as ~$200 at one point imo. Look at their rich & promising drug discovery pipeline  👇
#SupDup #Alzheimer #Parkinsons #Stroke #Anxiety #Dimentia

https://t.co/RG8MaWw2Ug


Summary: Building large long in TRUG targeting $1–$5 near- and long-term; favors patient investors over penny flippers.

$TRUG - Building a large long position as I see this slowly rising to between $1 - $5 in NT & LT. Let the penny flippers make little money like they did with $LAES $WKEY $RR $LUNR $LUNRW $RKLB $LITM and others but real big bucks will be made by investors with patience & vision just like the above ones imo.
#SupDup


Summary: Predicts RR will reach $10+ this year from current $3, citing past moves in similar names.

$LUNR went up from $3.30 to $22+
$LUNRW went up from <$0.70 to $11+
$RKLB went up from <$6.15 to $31.50+
$RR $3 rn will go up from $0.75 to ........you guys wanna guess? My answer is we will see at $10+ one day this year with many ups & downs imo
#SupDup


Summary: Long RR at $1 as a ground-floor play on humanoid robot adoption expanding like Tesla EVs did.

Remember 5 years ago when $TSLA #Tesla EVs were a rare sighting everywhere except California. Now they are all over in USA and many other countries.
Same will happen in next 5 years with AI powered Service #Humanoid #Robots, so this is a ground floor opportunity to get into $RR $1 imo
#SupDup


Summary: Confirms still holding all ten positions; ongoing long across TRUG, AIMD, RR, EDBL, MBIO, ALLR, SOBR, TSSI, CING, ANVS.

PLEASE stop messaging me and asking here if I still own $TRUG $AIMD $RR $EDBL $MBIO $ALLR $SOBR $TSSI $CING $ANVS.
Answer is YES I still own them. If you can't handle stock going up & down then you should be focusing on your day job and should not be in stocks trading/investing imo.
#SupDup


Summary: Buying MSTR at $407 after Citron dip, adding aggressively below $400; bullish on BTC at $98K+ boosting MicroStrategy NAV.

$MSTR - Thanks Citron Research @CitronResearch for providing with an opportunity to buy at $407, much cheaper than earlier price of $545.  IF it dips to <$400 I will be adding more aggressively because $BTC #Bitcoin price is today at record $98,000+ which means Micro Strategy's holding value jumped significantly imo
#SupDup @saylor

https://t.co/fvy1iBOADY


$BTC #Bitcoin price is today at record $98,000+ which means Micro Strategy's holding value jumped significantly


Summary: Adding to EDBL position at $0.32 for short-, near-, and long-term holds.

$EDBL $0.32 - Adding for ST, NT & LT
#SupDup


Summary: Expects KSCP to break into the $13+ (teen) range from $12.80.

$KSCP $12.80 - Close to entering Teen imo   🤑
#SupDup


Summary: Adding to long position in RR at $1.10–$1.25; still sees it as cheap vs SERV.

$RR - I showed you all at $0.75 a few days ago bought at $0.74 - $0.85, yesterday I added more at ~$1.10 and even today I bought at $1.25
Compared to $SERV this one is way cheap imo  🤑
#SupDup


Summary: Buying ANVS dips; expects spike to $10+ within a few months.

$ANVS <$6.40 - Buying on dips for ST & NT.
It could spike suddenly to $10+ in next few months imo.
#SupDup


Summary: Added to long position in RR at $2.80–$2.90 across short, near, and long-term timeframes.

$RR - Added more at $2.80 - $2.90 for ST, NT & LT
#SupDup


I am accumulating building a long position for ST, NT & LT because of thin equity float and Third Quarter Revenue of $70.1 Million, Up 689%

Summary: Accumulating TSSI long for short-, near-, and long-term on thin float, 689% revenue growth, and 1,166% net income surge.

$TSSI ~$9 - I am accumulating building a long position for ST, NT & LT because of thin equity float and   👇
Third Quarter Revenue of $70.1 Million, Up 689%
Net income of $2.6 million, up 1,166%
Love the SUPER DUPER growth here and the strong growth of sales & profits trajectory they are on  🚀  imo
#SupDup


Summary: Long KSCP; sees it rising to $20–$30 this year driven by institutional discovery and a short squeeze.

With a few good trades and few hours of having logged in, I did manage to make $15k+ today while on vacation   🤑   😃
Fell asleep and didn't sell a single share of $KSCP or else could have made more money. I see this stock slowly rising to $20 to $30 this year with many ups and downs. Once the penny flippers are gone, Institutional Investors discover and start buying & short squeeze happens stock will be in Teens imo.
Hope you all had a green day.
#SupDup


in next 1 yr where visibility is clear I see the company faring very well... ASML is a leader and should be able to maintain their leading edge

Summary: Cautiously bullish ASML over next 12 months; leader with clear visibility, though prefers faster-return low-priced names.

industry='Semiconductor Equipment & Materials'

$ASML  $660 - $680 = I like it but IF there is any slowdown in semiconductor sector it could drop fast. Although in next 1 yr where visibility is clear I see the company faring very well. It is competitive sector with many players but ASML is a leader and should be able to maintain their leading edge.
I would rather trade/invest some low priced stocks where returns could be quicker imo

@SuperDuperInvst  what’s your take on ASML?


Summary: Buy HOUR under $1.75 ahead of earnings release, sell after ER.

$HOUR <$1.75 - Buy now, sell after ER   🤑
#SupDup


Summary: Buy ORKT at $0.53; expects recovery to $1+ target.

$ORKT $0.53 - LOAD UP, it will be back to $1+ with a little PAYtience imo.
#SupDup


Summary: Expects strong gap up in DTSS tomorrow morning.

$DTSS $2.45 - STRONG GAP UP tomorrow morning imo. Keep your eyes on it   🤑
#SupDup


Summary: Long ORKT with near-term PT $2.50–$5 and long-term PT $7+; Maxim initiates at Buy/$5 PT.

$ORKT $1.40 -   Orangekloud Technology initiated by Maxim group at a Buy rating with Price target of $5
#SupDup

---

$ORKT - Few days ago I had mentioned that my conservative NT PT is $2.50 - $5, LT PT $7+ imo


Summary: Buying RR at ~$2.35; decisively bullish.

$RR ~$2.35 - Time to LOAD & LOCK for me   🤑
#SupDup


Summary: Long TSSI; author sees conservative fair value $33–$47 vs current <$21, citing 523% revenue growth and extreme undervaluation vs NVDA/DELL/RKLB peers.

$TSSI <$21 - Last qtr revenue growth was 523%. Just $500 mln co with $400 mln in sales rn = Extremely UNDERVALUED.
TSS, Inc growth rate this year will be much higher than most other hot tech companies. Should be a $1.5 bln co at least even today based on its fundamentals compared to huge PE ratios of $NVDA and $DELL. For example if you compare with $RKLB fundamentals and potential, this stock should be $50+ even right now.
But fair value conservatively in my opinion currently should be between $33 to $47 price range imo.
#SupDup


Summary: Short SOBR; expects continued downside next week.

$SOBR - Keep shorting, next week will do short circuit and give you current imo   🔌 ⚡  👨🔧   🤑
#SupDup


Summary: Considering tripling ALLR position on dips below $0.70; strongly bullish.

@robsmusic2 Yes I am considering to TRIPLE my holding in $ALLR at <$0.70 on dips.

@SuperDuperInvst @SuperDuperInvst RU still feeling confident about $ALLR DD?  If so, feelings about loading up today?


Summary: Long KSCP from $10.60 with near-term PT $20–$22 on US Air Force partnership driving order flow.

$KSCP $10.60 rn - My NT PT is $20 - $22
Expecting many more orders now that they are in bed with US Air Force imo
#SupDup


Summary: RR undervalued at $3.25, should be $5+; KSCP undervalued at $10.75, should be at least $15.

$SERV $21+ rn comparatively $RR $3.25 should be $5+ and $KSCP $10.75 should be at least $15 if not higher imo
#SupDup


$KSCP $10.75 should be at least $15 if not higher imo


Summary: Bullish ALLR: $5M buyback imminent + small-cap biotech funds expected to enter once price crosses $1.

$ALLR -  👇 ✅  $5 mln stock buy back by co should kick in soon, once $1+ we should see several small cap biotech hedge funds coming in taking a long position imo
#SupDup

$ALLR net cash per share $3.87 and 4.4M float. 1 sweep detected a few minutes ago (probably the repurchase program is already taking place).


Summary: Short RGC: no real revenues yet $35B valuation; price target under $20.

Drug Manufacturers - Specialty & Generic

$RGC $63 rn - Dropped to $53 earlier but this company with no real revenues and valuation of $35 bln makes absolutely no sense. I repeat sooner or later it will be under $20 imo
#SupDup

$RGC $70+ in AHrs after touching intraday high of $83.50+ = SELL SELL SELL, take your profits and run. Great Short Sell too. Sooner or later this will be back to $10 - $20 imo
#SupDup


Summary: Actively buying GNPX on dips at $0.41.

$GNPX $0.41 - Buying again on dips  🤑
#SupDup


Summary: IINN trading under $0.95 is undervalued; author sees fair value above $1.50.

$IINN <$0.95 rn, But based on my DD, I would say it would be UNDERVALUED even at $1.50 imo
#SupDup #Disruptive


Summary: Long RNAZ at $1.80–$1.90, targeting $2.70–$4.40 short-term on short squeeze potential and management not diluting at highs.

$RNAZ - Bought $1.80 - $1.90
I expect stock rising in the range of $2.70 - $4.40 in ST. Heavily short sold, MM & Shorts gonna be tapped. Think Mgmt could have easily raised more cap when stock had jumped to teens but did not. May be there is a reason they didn't imo
#SupDup


Summary: Loading up on KSCP dips across all timeframes; expects AI security robot orders from police, govt, and DOD under Trump administration.

$KSCP $10.25 - I am LOADING UP on dips for ST, NT & LT because during Trump admin this #AI based Safety & Security Robots should get even some orders from Police Departments, Govt Buildings/Agencies and possibly US DOD imo
#SupDup


Summary: Bullish RR: speculative NVDA investment scenario could push stock from $2.75 to $7–$10+.

$RR $2.75 - Imagine if $NVDA invests $100 mln then where would the stock be upon the news?
I would say easy jump to $7 - $10+   🤑
It is wishful thinking for now but it is possible imo  !
#SupDup


Summary: Bullish NIXX on Russell 3000 inclusion expected to attract institutional buying.

industry='Staffing & Employment Services'

$NIXX - Don’t forget about addition to Russell 3000 E(R) Index means more institutional investors now could be joining our party imo 👇🏼  🤑
#SupDup

https://t.co/f7DREaIx89


Summary: Adding to RNAZ long on dips in the $5–$5.40 range.

$RNAZ - Will be adding more on dips $5 - $5.40
#SupDup


Not just in China but even in USA and some other countries it has been on surge lately so precautionary measures are coming into effect imo

Summary: Bullish IINN: hMPV surge spreading beyond China to USA and other countries will drive demand for ART100 production ramp.

$IINN - Not just in China but even in USA 👇 and some other countries it has been on surge lately so precautionary measures are coming into effect imo
#SupDup

https://t.co/O0j637E5Ih

Inspira™ ( $IINN ) is preparing for potential production ramp-up of the INSPIRA™ ART100 amid the hMPV outbreak in China. Ensuring readiness to meet healthcare needs globally. Read more >>
https://t.co/a3rVOkkLu4 https://t.co/RLM6V2d9WI


Summary: IINN below $0.85 seen as heavily undervalued; bullish stance.

$IINN <$0.85 = HEAVILY UNDERVALUED imo
1 more EXCITING NEWS !!
#SupDup

https://t.co/WRRkr0pzYd


Summary: Anticipates positive mgmt news triggering a large short-covering rally.

$SOBR - Most likely we should hear some long overdue good news from mgmt and IF that happened watchout for a huge short covering rally imo
#SupDup


Summary: Bullish SOUN; calls out Piper Sandler downgrade as wrong and urges buying.

$SOUN $11.10+ rn, thanks a lot to the weak hands that sold at <$10.75 at open and to the moron or agenda driven Piper Sandler analyst that downgraded the stock retaining PT when it was time to upgrade and BUY BUY BUY imo
#SupDup

$SOUN - $10.75 LOADING UP heavily on dips
#SupDup


Summary: Strong buy on Rolls-Royce below $1.65 for patient investors with vision.

@derArztBasha $RR<$1.65 = BUY BUY BUY if you have vision and patience imo


I am LOADING UP. It will be $3 to $5 by end of this year imo

Summary: Aggressively buying MOB at $1.65 with target of $3–$5 by year-end.

$MOB $1.65 - I am LOADING UP. Join me if you like.  It will be $3 to $5 by end of this year imo  🤑
#SupDup


Summary: Adding to KSCP on dips; bullish on likely future US govt/DOD orders.

$KSCP - Adding on dips $10.25 - $10.45 range.
Huge US govt / DOD orders likely in future imo.
#SupDup


Summary: Bullish SOUN at $10.20; loading up for day/swing and near-term trades.

$SOUN $10.20 rn - LOAD UP time for me 4 DT/ST & NT imo.
#SupDup


Summary: Doubling position in ALLR at ~$1.05; bullish accumulation.

$ALLR ~$1.05 - Doubling my holding
#SupDup


Summary: Expects CING to rocket in the short term; holding with patience.

$CING $4.20 - Should take off one day in ST like a  🚀
PAYtience imo
#SupDup


Summary: Holding and planning to add more RNAZ on dips; bullish ongoing position.

@_JasonLL_ That's your decision. I am NOT selling it but plan to add even more on dips.

@SuperDuperInvst should i cut $RNAZ? down 35% and I can’t really afford to DCA on it.


Current <$1.5 mln valuation is dirt cheap... good to gamble given Cancer is a huge TRILLION $ global market

Summary: Long RNAZ: sub-$1.5M valuation seen as dirt cheap with buyout potential and massive cancer market TAM despite risk.

$RNAZ $1.80 = Current <$1.5 mln valuation is dirt cheap, Some large pharma should buyout for their amazing science that can possibly stop the spread and/or even kill deadly Metastatis cancer cells. Do your DD on this company's science & pipeline to see why I like this even though it is risky. If you have vision and patience it is good to gamble given Cancer is a huge TRILLION $ global market imo
#SupDup


Summary: Buying and holding ALLR at $1.15–$1.20 price range.

$ALLR $1.15 - $1.20 = LOAD & LOCK for me   🤑
#SupDup


Summary: Expects NVDA to report strong numbers with at least in-line guidance; bullish into earnings.

Imagine if $NVDA disappoints upon ER this week.
Personally I think they will report strong numbers and issue moderate to surpassing expected outlook.
Coming week will be very interesting. Embrace for sort of roller coaster ride thrill as we will see rises and falls but overall markets will provide great opportunities this week to make money due to wild swings imo
#SupDup


Summary: Strong buy on IINN below $0.70 with a $2+ price target sometime this year.

$IINN <$0.70 = BUY BUY BUY for me as this will be $2+ sometime this year imo
#SupDup


Adding more and more heavily & fearlessly on dips from a day ago's spike to $7.70 to sell again someday at much higher prices imo

Summary: Aggressively buying KPRX dips, expects to sell at much higher prices.

$KPRX - Adding more and more heavily & fearlessly on dips from a day ago’s spike to $7.70 to sell again someday at much higher prices imo
#SupDup


Yes I'm holding and will be adding more on dips

Summary: Holding SNOA and plans to add more on dips; bullish ongoing position.

@Mani_Raval Yes I’m holding and will be adding more on dips

@SuperDuperInvst $SNOA still worth holding pal ?


Summary: Long ORKT to $2+ by Feb 3, 2025.

$ORKT - I still believe $2+ will be seen by 2/3/25 imo  🤑   🤞
#SupDup


Adding heavily for ST, NT & LT. Round 2 rally within a week imo

Summary: Heavily adding TRNR long on ultra-thin ~650k float; expects another rally within a week.

$TRNR ~$1.10 - Adding heavily for ST, NT & LT.
Float I believe is super duper thin at just ~650k shares.
Round 2 rally within a week imo    🤑
#SupDup


Summary: Adding SMCI on dips, targeting $40–$44 spike this week.

$SMCI - Could spike to $40 - $44 this week, I am adding on dips for ST imo
#SupDup


Summary: Conditional long IINN under $0.90 as potential huge beneficiary if a Covid-like virus outbreak emerges from China.

$IINN <$0.90 - China has been in news with new HKU5-CoV-2 virus emerging.  IF any #Covid19 kind of virus emerges (Ihope not), this company will be huge beneficiary imo    👇
#SupDup

https://t.co/pgIhhK9HzP


Summary: Buy SOUN on dips; oversold across all timeframes from day-trade to long-term.

$SOUN <$10.75 rn - Time to load up on dips for DT/ST but great NT & LT buy. Stock is OVERSOLD now imo
#SupDup


Summary: Still long RR, holding and adding on dips despite drawdown from $5.35; believes in its future.

@aces_rolled $RR $2.20 - YES. Wish I sold them on spike to $5.35 but since I believe in its great future I have decided to hold on and have been adding more on dips.

@SuperDuperInvst Do you still own RR? So brutal.


Summary: Expects TSSI to quickly rebound from ~$21 to $25–$30; suggests future $50–$150M capital raise at $30+/share.

$TSSI $21.35 - Will jump up quickly to be back to $25 - $30
Mgmt should do a $50 mln to $150 mln funds raising at some point @ price of $30+/share to expand the manufacturing capacity / acquisition and for general operational purpose imo.
#SupDup


Summary: Adding to long RNAZ position on dips, planning to double the position.

$RNAZ <$1.10 - Adding more on dips with a plan to double my long position
#SupDup


Summary: Still holds SOBR; ongoing long position.

@SuperDuperInvst Are you still holding $SOBR ???


Summary: Bullish on TSSI, MOB, and AIMD heading into next week; expects significant gains.

Beautiful day with $TSSI and $MOB spiking strongly   🤑
Next week gonna be great as we gonna make a LOT OF MONEY imo.
Keep your eyes on $AIMD
Monday US stock market will be closed for Memorial Day. Thanks to all the Veterans for your services. Enjoy the long weekend  ❤
#SupDup


Summary: Strong buy on KSCP under $12 across short, near, and long-term timeframes.

$KSCP <$12 - LOAD & LOCK for me for ST, NT & LT
#SupDup


Summary: Bullish on MOB at $2.15; operates in AI defense/drones/cybersecurity/robotics, supplier to US DoD.

$MOB $2.15 - Operates in the hottest sector of #AI based #Defense, #Drones, #Cybersecurity & #Robotics.  They are supplier to US Dept of Defense and other major world militaries per the mgmt  😍   🤑
Stock to keep an  👀  on imo
#SupDup


Summary: Actively adding to long MOB position on dips in the $2.60–$2.75 range.

$MOB - Adding more on dips at $2.60 - $2.75 range
#SupDup


Summary: Long SOUN as a major beneficiary of AI emergence.

$SOUN - Huge beneficiary of #AI emergence imo
#SupDup

ICYMI 📺: SoundHound AI's CEO and Co-Founder, Keyvan Mohajer, joined @CNBCFastMoney earlier this week to speak about the next wave of AI innovation 🤖

Check it out: https://t.co/ZmIJdBrNEK https://t.co/KeaudBwXye


Summary: Strong buy call on MOB at $2.50 across short, near, and long-term timeframes.

$MOB $2.50  = LOAD LOAD LOAD for ST, NT & LT imo   🤑
#SupDup


Summary: Accumulating SOBR on dips, targeting continued upside from ~$0.95.

$SOBR $1.25 rn   🤑
#SupDup

https://t.co/uBsKyR9WGl

$SOBR ~$0.95 - Buying more again on dips for round 3 imo    🤑
#SupDup


$KPRX $2.85 ... are way more attractive and in much advanced stages of clinical trials and much more attractive given their promising phase 2 or phase 3 stage clinical trials ... All 3 are currently trading at DIRT CHEAP valuations imo

Summary: Bullish on KPRX, CING, ANVS, ALLR as dirt-cheap biotech names in advanced clinical stages, potential buyout candidates at hefty premiums.

$VERV - I believe Verve Therapeutics Inc is a Pre Clinical
Stage company that yesterday got a $1.3 bln buyout offer from Eli Lilly. Compared to it $KPRX $2.85 $CING $4.50 $ANVS $2.65 and $ALLR $0.80 are way more attractive and in much advanced stages of clinical trials and much more attractive given their promising phase 2 or phase 3 stage clinical trials. Let’s hope one of these days we get lucky hearing about their buyouts at hefty premiums. All 3 are currently trading at DIRT CHEAP valuations imo
#SupDup


$CING $4.50 ... are way more attractive and in much advanced stages of clinical trials and much more attractive given their promising phase 2 or phase 3 stage clinical trials ... All 3 are currently trading at DIRT CHEAP valuations imo


$ANVS $2.65 ... are way more attractive and in much advanced stages of clinical trials and much more attractive given their promising phase 2 or phase 3 stage clinical trials ... All 3 are currently trading at DIRT CHEAP valuations imo


$ALLR $0.80 ... are way more attractive ... All 3 are currently trading at DIRT CHEAP valuations imo


Summary: Bullish IINN: new high of day, heavy accumulation, potential short squeeze and breakout.

$IINN - NHOD rn. Heavy accumulation going on. Watch out for short squeeze & breakout imo  🤑
#SupDup


Summary: Still holds a long position in ALLR.


Summary: Long KSCP below $10.35, doubling position; potential $15+ jump on Air Force orders, seen as undervalued near/long-term buy.

$KSCP <$10.35 = Slowly buying and thinking of doubling my long position. IF they get any orders from US Airforce, this stock could jump $15+ on the news. Great NT & LT buy at current low valuation imo
#SupDup

#Knightscope selected by the innovation arm of the United States #AirForce, AFWERX, for a Phase I SBIR contract to streamline and improve Air Force Installation Security procedures and outcomes!

Read full release here - https://t.co/M923iKCSsQ
$KSCP https://t.co/kKgttATRwT


Summary: Strong buy on EDBL under $0.20; sub-$6M mkt cap seen as dirt cheap, 100–300% sales growth expected with ~$60M revenue in 2025.

$EDBL <$0.20 = LOAD LOAD LOAD for me. Current mkt cap of <$6 mln makes this dirt cheap and very attractive NT & LT investment. Sales this year should rise between 100% to 300%. IF all goes per mgmt plans we should see revenues of ~$60 mln in 2025 imo
#SupDup


Summary: Bullish KPRX at $3.20; expects KIO-104 Phase 2 to generate lucrative licensing deals like KIO-301; urges loading up at current cheap price.

$KPRX $3.20 - Their Retinal Inflammation drug KIO 104 in phase 2 clinical trials should be next to get lucrative licensing deals for US, Europe, Asia and other territories just like we saw with their KIO 301 for Retinitis Pigmentosa. LOAD UP and hold tight while the price is dirt cheap currently imo  🤑
#SupDup


Summary: Bullish IINN; considering doubling long position, expects 2–3x price appreciation sometime this year.

$IINN $0.70 - Getting very tempted to double my long position after reading this PR. It seem easy DOUBLE OR TRIPLE sometime this year imo
#SupDup

https://t.co/einUhY96Gw


Summary: Bullish IINN from $0.70 to $2+ on steady accumulation.

$IINN $0.70 - Under slow & steady accumulation. Don't tell me I didn't tell you when this jumps to $2+ some day imo    🤑
#SupDup


Summary: Bullish ORKT from under $0.75 to $2–$5 near-term target.

@JoshHorton12345 @MathiasMylle $ORKT <$0.75 - Will be $2 to $5 in NT it needs paytience imo

@SuperDuperInvst @MathiasMylle Thanks  for the update 🙏🏼


Summary: Long ALLR; expects $1.20–$1.45 within a week on a $1+ close.

$ALLR - Close of $1+ will make rise to $1.20 - $1.45 within a week imo
#SupDup


Summary: Buying SOUN dips at $12–$12.25 for a day/short-term trade after spike to $13.30.

$SOUN $12 - $12.25 time for me to buy on dips from earlier spike to $13.30 for DT/ST imo
#SupDup


Summary: Adding to long position in ALLR under $1.

$ALLR <$1 - Slowly doubling my long position
#SupDup


Summary: ALLR could rise from $1.15 to $1.25–$1.45 tomorrow if markets are green.

$ALLR $1.15 - Could rise to between $1.25 - $1.45 tomorrow IF markets are green imo
#SupDup


Summary: Still holds MBIO; ongoing long position with positive view.

@staktrader @mustyballz @FU16HJ $MBIO - I still own and like the company  🤑

@SuperDuperInvst @mustyballz @FU16HJ What do you think about $MBIO?


Summary: Bullish IINN; expects gradual move from $0.60 to above $1.

$IINN $0.60 - Slowly & Steadily will be marching towards $1+ imo  🤑
#SupDup


Summary: Bullish on smaller robotics players RR, KSCP, and AIMD as sector beneficiaries.

@StockSavvyShay Agreed. Also smaller players in the robotics sector like $RR $KSCP $AIMD imo

ROBOTICS IS CLOSER THAN YOU THINK

• $TSLA is leading with real-world humanoid AI
• $NVDA is fueling robotic intelligence
• $ISRG is transforming surgery with robotics
• $AMZN is automating logistics at scale

 https://t.co/mkndUFxWRL


Summary: Buying SOBR under $1; expects short squeeze trapping shorts and market makers.

$SOBR <$1 - LOAD & LOCK is what I am doing. Mark my words one day not too long from today, Shorts & MM are going to get trapped imo   🤑
#SupDup


Summary: Expects IINN to double or more within 6 months.

@punchfeedX It should double or even be much higher within next 6 months imo

@SuperDuperInvst Hello SupDup. Any updates on the $IINN play. I like it as well. Thanks again !


Summary: Bullish ORKT long-term on Singapore management quality and cheap cash valuation; SE cited as a comparable success story.

$ORKT - Total manipulation today by either MM or God know who but I don't care for the price because I am glad me and you all are getting to buy at dirt cheap cash on hand valuation. Singaporains are one of the most efficient in the world. I have been there so I know it well. I would bet on them. This company will do very well in future just like $SE ($65+ bln value) which is also Singapore based mgmt imo
#SupDup


just like $SE ($65+ bln value) which is also Singapore based mgmt


should rise very strongly… With next few good PRs we could be closer to $5 or even higher

Summary: Long NIXX from under $2 targeting $5+ on upcoming PR catalysts once penny flippers exit.

$NIXX <$2 - Slowly and steadily with many ups and downs should rise very strongly like $TSSI that I showed here at $8.75 that hit ~$33 quickly as most of you here know.
Wait till penny flippers are gone. With next few good PRs we could be closer to $5 or even higher. PAYtience imo   🤑
#SupDup #Disruptive


Summary: Expects positive news catalyst for SOBR within 1-2 weeks; implied bullish.

$SOBR $1 - Co has not released any new news in over 2 months. I have a feeling we will hear some good news within next 2 weeks most likely as early as next week imo   🤞
#SupDup


Summary: Adding to long ALLR below $1.15 on genomics/cancer diagnostics revenue potential and thin float.

$ALLR <$1.15 - Doubling my long position in this Anti Cancer biotech with thin equity float and ~$15 mln cash on hand.
Allarity Medical Laboratory as a direct provider of revenue-generating, high-precision genomic services, establishing it as a valuable complementary asset for the Company. Genomics, Gene Expression & Diagnostics for #CANCER = Huge revenue potential like $WGS imo

About the Drug Response Predictor – DRP® Companion Diagnostic Allarity uses its drug-specific DRP® to select those patients who, by the gene expression signature of their cancer, are found to have a high likelihood of benefiting from a specific drug. By screening patients before treatment, and only treating those patients with a sufficiently high, drug-specific DRP score, the therapeutic benefit rate may be significantly increased. The DRP method builds on the comparison of sensitive vs. resistant human cancer cell lines, including transcriptomic information from cell lines combined with clinical tumor biology filters and prior clinical trial outcomes. DRP is based on messenger RNA expression profiles from patient biopsies. The DRP® platform has proven its ability to provide a statistically significant prediction of the clinical outcome from drug treatment in cancer patients dozens of clinical studies (both retrospective and prospective). The DRP platform, which can be used in all cancer types and is patented for more than 70 anti-cancer drugs, has been extensively published in the peer-reviewed literature.
#SupDup


Summary: Prefers ALLR as the safer buy at $1.05, actively adding today.

@baconelf @SUPER I like them both equally and been adding today but $ALLR $1.05 is more safer imo

@SuperDuperInvst @Super if you could pick just one to buy, which would it be, RNAZ or ALLR


Summary: Still holds EDBL shares; ongoing long position.

@TGBTG7777 I still own many $EDBL but I only listed a few on that list.

@SuperDuperInvst Did you leave off $EDBL by mistake or on purpose?


Summary: Actively buying SOUN below $11.40; fearlessly loading up.

$SOUN <$11.40 - LOADING UP fearlessly
#SupDup


Summary: Strong buy on ALLR under $1.10.

@AnTran33026 $ALLR <$1.10 - Its a Buy Buy Buy for me.
#SupDup https://t.co/lO1MAh5ymx


Summary: Bullish AIMD on unique AI-powered smell-sensing tech with humanoid/industrial robotics applications; author views it as disruptive.

$AIMD - It has unique Smell Sensing #AI powered Nose that can be used in #Humanoid #Robots and many other industrial #Robotics applications for safety. It is #Disruptive #Technology imo
#SupDup @CathieDWood


Summary: Expects a broad US tech sector rally Monday on Trump tariff exemptions for smartphones, computers, and microchips.

👇🏼   😍
President Trump exempts smartphones, computers, microchips from new tariffs.

Huge tech rally on Monday morning based on this news imo   🤑
#SupDup

https://t.co/DdycRCPayo


Summary: Holds ALLR and RNAZ long; confident in gains from their anti-cancer clinical pipelines.

$ALLR $1.05 & $RNAZ $1.10 - Both biotechs have VERY EFFECTIVE and PROMISING clinical pipeline for various Cancers. I am doing my part by supporting these Anti #CANCER drug companies. I am hoping over the time they will succeed. I am confident I will be making a LOT OF MONEY but even if I lose money that's okay.  I will be happy to see many people & their family not suffer and/or lose lives battling different kinds of Cancers.
Folks that have a family member or friend or even themselves battled & survived Cancer knows the need for having drugs & treatments that can help or cure imo.
I don't trade with emotions but I am a caring human being so I care.
#SupDup


Summary: Long ALLR under $1; urging patience, comparing to GNLX which surged ~200% after a similar stagnant period.

@TheVincible Bro have patience with $ALLR <$1. $GNLX ~$6 was dead and stagnant for months around $2 when I kept screaming buy and now it is up ~200% so quickly imo
#SupDup

@SuperDuperInvst Any tentative timelines on when we could see a movement on this bro


Summary: Long SOUN as a leading beneficiary of the large global Agentic AI opportunity.

$SOUN - Agentic AI will be enormously large opportunity worldwide so companies like SoundHound AI that is at the forefront should emerge as a great beneficiary imo
#SupDup


Summary: Aggressively buying SOUN at sub-$10 levels.

$SOUN <$10 = BUY BUY BUY for me. I am LOADING UP  🤑
#SupDup


Summary: Bullish on EDBL; expects positive performance even if not to the AI-generated analyst target.

@alwabesi1980 😍   I doubt it will rise that much but it should do well imo

@SuperDuperInvst I searched for $EDBL stock target with AI and the answer is ///
 EDBL stock price target for 2025 is quite ambitious, with the average analyst price target of $37.92, representing a +18,528% upside from the last recorded price of $0.2036.

Do you expect the artificial


I'm building a large long position for ST/NT/LT at this dirt cheap valuation

Summary: Building large long position in SNOA at $2; fundamental fair value seen at $5–$15 with thin float as catalyst.

$SNOA $2 - Based on current fundamentals and potential this stock should be at least between $5 - $15
Super thin float and outstanding share count so any exciting news could make stock skyrocket imo.
I’m building a large long position for ST/NT/LT at this dirt cheap valuation.
#SupDup


Summary: Bullish on MOB as an Israeli drone/cybersecurity/robotics play supplying US DoD.

$MOB - Israeli #Drone #Cybersecurity and #Robotics play, keep your  👀  on it. It supplies to US Dept of Defense as well imo
#SupDup


Summary: Expects IINN to rise from below $0.90 to $1–$1.50 next week.

$IINN <$0.90 - Next week it will be $1 - $1.50 imo   🤑
#SupDup


Summary: Bullish SNOA on new Medline + WellSpring partnerships expected to expand US sales in 2025.

$SNOA - Anyone working in or familiar with Medical industry would know how big is Medline brand. It’s HUGE with 2022 sales of $21+ billion and was acquired for $34 billion in June’21 by consortium of PE firms Blackstone, Carlyle and Hellman & Friedman.

Amy Trombly, CEO of Sonoma Pharmaceuticals "We have also announced significant new business developments which we believe will lead to continued growth for our company. These developments include the establishment of new partnerships with Medline Industries, LP and WellSpring Pharmaceutical Corporation, both of which are expected to expand our U.S. sales in 2025."
#SupDup


Summary: Strong buy on KPRX at sub-$3, targets $10+, across short, near, and long term.

$KPRX - $10+ stock available rn at <$3 = LOAD LOAD LOAD for me for ST, NT & LT imo
#SupDup


Summary: Expects DTSS to spike and gap up Monday on wall removal.

$DTSS - Wall getting torn down so watch for a sudden spike and gap up Monday morning imo  🤑
#SupDup


Summary: DTSS heavily shorted and ripe for a short squeeze, expected to spike strongly like TSSI.

$DTSS $2.30 - Can it spike strongly and quickly like $TSSI? Yes it very well can because it is heavily short sold and ripe for a squeeze imo.
#SupDup


Slowly & Steadily adding more and more on dips as I see this disruptive medical devices company's stock rising very strongly over the time

Summary: Accumulating IINN on dips; expects strong price rise driven by disruptive ventilator tech with no tariff exposure.

$IINN ~$0.60 - Slowly & Steadily adding more and more on dips as I see this disruptive medical devices company’s stock rising very strongly over the time. No impact due to tariffs so it’s a safer bet that way too. Their innovative unique ventilator can make currently used mechanical ventilators obsolete imo
#SupDup


$ALLR $1 - Many reasons, best being the new mgmt is dynamic and seem to have sharp focus on growing shareholder value... the stock is heavily short sold so it is ripe for a massive short covering and rally imo

Summary: Long ALLR on new management, resolved legal issues, pipeline drugs, buyback, genomics revenue, buyout appeal, and short-squeeze potential.

$ALLR $1 - Many reasons, best being the new mgmt is dynamic and seem to have sharp focus on growing shareholder value. Worst is behind the company now that all legal issues that brought the stock drop a lot are resolved. Company has very promising Anti Ovarian cancer drug in phase 2 trials, Another one for recurrent Small Lung Cell cancer drug that recently got fully funded from VA dept, company is fairly capitalized, have a $5 mln authorized stock buyback, its Genomics lab now generates revenues from other biotech research companies, its unique and patented DRP potential and huge revenue opps with out licensing their drug(s) for US and Global rights. I also believe this company at its under $5 mln market value makes it very attractive buyout candidate for a larger biotech or pharmaceutical company. Add to this the stock is heavily short sold so it is ripe for a massive short covering and rally imo
#SupDup

@SuperDuperInvst Why are you so optimistic?


Summary: Aggressively buying SNOA at $3.15 for short-term and near-term gains.

$SNOA $3.15 - I am LOADING UP for ST & NT. Join me if you like   🤑
#SupDup


Summary: Bullish EDBL; under slow and steady accumulation.

$EDBL - Under slow & steady accumulation imo  🤑
#SupDup


Summary: INVZ below $0.90 seen as a good buy for both near-term and long-term.

@OndutyTech26010 $INVZ <$0.90 looks like a good buy for NT & LT imo

@SuperDuperInvst beloved SupDup, is #INVZ dip-worthy or deep-s**t?


Summary: Long TSSI; author holds and expects significantly higher prices in near and long term from current $12.55+.

$TSSI $12.55+ rn   🤑
In NT & LT this will be way higher imo
#SupDup

$TSSI <$11.70 = GIFT & SCREAMING BUY.
I am loading up heavily today on fire sale prices for DT, ST, NT & LT. New coverage and upgrade in ST will push this to $13 - $17 range quickly imo  🤑
#SupDup


Summary: Still holding Knightscope and plans to buy more to cost-average down.

Knightscope Inc trades as KSCP on Nasdaq

@DanDell263926 NO I will be buying more to cost avg

@SuperDuperInvst Have you dumped your knightscope?


Summary: Long RR on rising demand for service/humanoid robots as labor shortages intensify post-Covid and with deportations.

$RR $2.20 - Labor shortage has been plaguing USA since Covid19 and now we illegal migrants deportations it will intensify. Robots can substitute most of these open jobs now with AI driven service robots that can do simple to complex functions from making tea/coffee, drinks, food, serving stuff and moving goods within industries, cleanings, assembly work, packaging, etc.
Companies that make service & humanoid robots will see rising demands due to fill the labor force and for improved productivity & cost efficiences imo.
#SupDup


Summary: Predicts NIXX will be much higher by July 7, 2025 than its current price.

Stock market will close early at 1 pm est on Wed and reopen on next Mon.
$NIXX was $6.25 on 1/7/25, Any guesses on where it will be on 7/7/25? I predict much higher than where it is today for sure imo  🤑
#SupDup


Summary: Bullish DTSS after solid earnings and outlook; recommends buying for a quick gain.

$DTSS $2.15 - Solid ER and outlook. Grab some for quick $ imo
#SupDup


LOAD LOAD LOAD on dips. I have and will be adding heavily as I see all of them will spike significantly in ST/NT/LT imo

Summary: Actively adding to all seven small-caps expecting significant spikes across short, near, and long term.

Be back from vacation tomorrow.
Those that added $ALLR at $0.65 recently on dips should be happy as the stock now is $1.05+
Told you all PAYtience !
LOAD LOAD LOAD on dips. Don’t miss out on
$SNOA <$2.20
$ORKT <$0.55
$IINN $0.55
$RR <$1.80
$CING <$4
$KSCP <$4.50

I have and will be adding heavily as I see all of them will spike significantly in ST/NT/LT imo   🤑


LOAD LOAD LOAD on dips. Don't miss out on $SNOA <$2.20


LOAD LOAD LOAD on dips. Don't miss out on $ORKT <$0.55


LOAD LOAD LOAD on dips. Don't miss out on $IINN $0.55


LOAD LOAD LOAD on dips. Don't miss out on $RR <$1.80


LOAD LOAD LOAD on dips. Don't miss out on $CING <$4


LOAD LOAD LOAD on dips. Don't miss out on $KSCP <$4.50


Summary: Long TSSI to $35–$55+ by 2026 on monster AI hyperscale data-center demand.

$TSSI $22 - Should be seen between $35 - $55 or even higher in 2026 due to monster demand of its products that AI hyper scale data centers & related tech infrastructure is fueling. PAYtience should payoff very well for LT investors imo
#SupDup


Summary: Strongly bullish CING from ~$3.75, expecting 50–150% gain within 6 months.

$CING ~$3.75 - 90% chance stock will rise 50% to 150% within next 6 months imo
#SupDup


Summary: Still holds AIMD from initial purchase; ongoing long position.

@memestonks8 Yes I still own many from the 1 st purchase a month or so ago

@SuperDuperInvst @SuperDuperInvst your are the 🐐 do you hold $AIMD?


Summary: Shares HC Wainwright's $20 PT on RNAZ with evident enthusiasm, implying large upside from $0.90.

RNAZ $0.90 - Just out    👇   seriously?   😍
DJ Transcode Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co
#SupDup


Summary: Adding to KPRX position across short, near, and long-term timeframes.

$KPRX - Adding some more for ST, NT & LT
#SupDup


Summary: Actively accumulating SNOA; views it as extremely undervalued.

$SNOA - 15 times the trading volume of yesterday and highest today in last 15+ days    👀
I have been buying more and more as I feel stock is extremely undervalued imo   🤑
#SupDup


Summary: Expects KPRX to skyrocket similarly to TSSI's past run.

$KPRX $3 - Sometime it will skyrocket just like $TSSI did imo
#SupDup


Summary: Long ALLR: current ~$5M market cap vs perceived fair value $50M+; drug pipeline + genomics lab = attractive takeover candidate.

$ALLR $1.10 = <$5 mln current value. Based on everything, company's current market value should be at least $50 mln.  Dirt cheap value and huge future potential of this anti advanced #Ovarian #Cancer & recurrent Small Cell #Lung Cancer (SCLC) drug discoverer alongwith Genomics lab offering makes it an attractive takeover candidate. Patience will pay off HUGE someday with this one imo   🤑   💰
#SupDup #RT


Summary: Still holding ORKT at higher cost basis; expects price recovery.

@JoshHorton12345 $ORKT $0.45 - It will have its day imo, I am still holding many purchased at higher prices and not worried.

@SuperDuperInvst What’s your position in $ORKT ? I’m 60% down wondering if it’s too risky adding more money to average down


Summary: Expects ORKT to win new business from GITEX Asia 2025 Singapore event; bullish lean.

$ORKT - Expecting new business from this event in Singapore their home town imo
#SupDup

Meet Us at GITEX Asia 2025!
Discover how our eMOBIQ®AI build powerful apps with zero coding required — faster, leaner, and smarter.
📍 Booth HE-D96, Sands Expo & Convention Centre, Marina Bay Sands
🗓 23–25 April 2025
🕙 10:00 AM – 5:00 PM
#OrangeKloud #eMOBIQAI #GITEXAsia2025 https://t.co/HlY4GRKKVe


Summary: Long TSSI with $35–$55 target in 2026; author is heavily accumulating on dips.

$TSSI $22.70 rn  🤑
What did I say yesterday  👇🏼
Will be $35 to $55 in 2026 imo
#SupDup

$TSSI <$19.90 - LOADING UP heavily & fearlessly on dips. 2nd trench accumulation going on. Not worried at all actually I hope this drops once to $18 so I can triple my investment to sell all at between $30 - $50 or even higher within a year imo
#SupDup


Summary: Loading up on DTSS dips; targets $5–$10 from current ~$2.60.

$DTSS $2.60 - Selling off on good news but I am and will be LOADING UP more and more on dips.
This will be $5 - $10 stock down the road imo  🤑
#SupDup


Summary: Bullish RNAZ under $1.70 on low float + heavy short interest setting up a potential short squeeze on positive news.

$RNAZ <$1.70 - Their Anti #Cancer science is so effective that it destroys & stops the spread of Cancer Cells, even works on the most dangerous Metastatis cancer as per the mgmt. Check it out, you gonna love it.
Super Duper low float. Heavily short sold so any upbeat news will trigger massive short squeeze imo
#SupDup


Adding heavily, down the road don't tell me I didn't scream

Summary: Aggressively adding to NIXX at ~$2.15; strong forward bullish conviction.

$NIXX ~$2.15 - Adding heavily, down the road don’t tell me I didn’t scream  😉
#SupDup


Summary: SOUN rebounding from oversold conditions; bullish lean.

$SOUN - Slowly rebounding as it was way oversold imo   🤑
#SupDup


HUGE prospects given every mid size to large size enterprises have IT dept that has many in some cases 100's of API's... Globally this #Disruptive NO CODE app dev platform eMOBIQ should garner great interest & demand over the time imo

Summary: Bullish ORKT on its AI-powered no-code app dev platform eMOBIQ tapping large enterprise IT/API spend globally.

$ORKT - HUGE prospects given every mid size to large size enterprises have IT dept that has many in some cases 100's of API's - Mobile & Web Development budgets are huge part of the businesses. Imagine if they can save significant amount of time, labor, money and have better apps based on #AI.
Globally this #Disruptive NO CODE app dev platform eMOBIQ should garner great interest & demand over the time imo
#SupDup


Summary: Long IINN targeting $0.85–$0.97 then $1–$1.27 on a break above $0.80.

$IINN - Break $0.80, next stop $0.85 - $0.97, thereafter $1 - $1.27 imo   🤑
#SupDup


Summary: Expects ORKT to recover to $1+ once short-term traders exit, on any positive contract/product news.

$ORKT - Once the penny flippers are gone this will march back to $1+ with any upbeat contract or product news in coming weeks imo
#SupDup


Summary: Heavily loading IINN under $0.45, adding on dips for short-, near-, and long-term.

$IINN <$0.45 - LOADING UP heavily as I feel this is the best price and time to buy or cost average. I will be adding on any dips for ST, NT & LT imo   🤑
#SupDup


Summary: Strong buy on KPRX under $3; targets 200%+ gain within 2 years.

$KPRX <$3 = ABSOLUTE STEAL. LOAD UP on dips. It will be UP 200% or more within 2 years with PAYtience imo
# SupDup


Summary: Bullish EDBL; endorses quoted tweet's thesis that new crop-yield technology is a huge disruptive catalyst for the stock.

$EDBL - 👇 I agree, that's right. It could change the way farming is done. Imagine crops yield of 50% that too in 30% less time. That is why I say it will be HUGE & #DISRUPTIVE imo
#SupDup

@SuperDuperInvst the new technology can increase crop yields by 50% and shorten production cycles by 30%. I think this is an explosive discovery that can boost stock prices. $EDBL


Summary: Actively accumulating KPRX at $3–$3.25, bullish across short, near, and long term.

$KPRX $3 - $3.25  = Fearlessly accumulating at this absolute steal prices for ST, NT & LT imo  🤑
#SupDup


Summary: Doubling position in KSCP; expects the stock to double this year.

$KSCP $9.25 - Doubling my holding as I see this stock doubling easily this year imo   🤑
#SupDup


Summary: Bullish AIMD on potential for AI Nose/smell detection tech to be adopted by humanoid robot manufacturers worldwide.

$AIMD ~$0.70  - Imagine if the company down the road succeeds in installing their AI Nose (Smell Detection) in most of the Humanoids worldwide or licensing the technology to Humanoid manufacturers like $TSLA !
We all know robots will be seen all over the world whether visible or not visible to us.
This could be possibly a monster opportunity imo   🤑
#SupDup


Summary: Author added to RR position at ~$2, anticipating big near-term news catalyst.

$RR ~$2 now, it was great chance to add cheaply last week. Did any of you load up? I sure did   🤑
#SupDup

https://t.co/glrv0Hcp8J

$RR - Adding more because I have a feeling we gonna hear some big news in ST imo
#SupDup


Summary: Strong buy on SNOA at $3.20; targets $5–$10 by year-end after earnings report.

$SNOA $3.20 - BUY BUY BUY for me because after ER and by end of this year I see it easily between $5 - $10 imo  🤑
#SupDup


Summary: Bullish EDBL as a potential beneficiary of Trump's proposed ban on China buying US farmland.

$EDBL $0.23 - This could give a boost to US growers of produce like this company imo
US President Trump Looks to Ban China From Buying American Farmland
#SupDup

https://t.co/mQ15XVNbMX


Summary: Building large long position in KPRX under $3, targeting $10–$25 by end of next year.

$KPRX <$3 - LOADING UP more building a Super Duper large long position for ST, NT & LT as I see this stock rising to between $10 to $25 by the end of next year imo  🤑
#SupDup


Summary: Long DTSS with short-term target $2.50–$3.25 from current $2.25.

$DTSS $2.25 - Can it run like $MLGO ?
Would be nice but I believe $2.50 - $3.25 in ST is a sure thing with some paytience imo   🤑
#SupDup


Summary: Strong buy on CING below $3.75, targeting 50–150% upside this year.

$CING <$3.75 = LOAD LOAD LOAD, it will be UP between 50% to 150% sometime this year imo. Read today’s PR !  🤑
#SupDup


Summary: Buying TRNR under $1.60 on very thin float (~625k shares), expects low-float squeeze move.

$TRNR - Did some more DD on the company.
Bought and adding more rn <$1.60
Equity float is VERY THIN at 625k shares with outstanding at just 1.5 mln shares. Am I right?
This could possibly take off like $RNAZ and many other low float jumpers imo     🤑    🤞
#SupDup


Summary: Buying SOUN on dips at $10.40.


Summary: Adding heavily to EDBL under $0.23 on health-conscious trend driving organic produce demand.

$EDBL <$0.23- Adding heavily because Americans just like people all around the globe are becoming more health conscious. Eating locally grown farm fresh  organic produce is a new emerging trend.
Edible Garden grows and sells large variety of #Organic farm fresh #USDA certified healthy vegetables & herbs  that they sell in 5000+ store locations across USA including Walmart, Target, Stop&Shop, ShopRite, Kroger, etc imo.
Make American Healthy Again    💪   ❤🩹
#SupDup #MAHA


Summary: Expects a strong bounce next week driven by massive short covering.

$SOBR - Coiled like a compressed spring, wait it it releases. Expecting STRONG BOUNCE next week with massive short covering imo
#SupDup


Will be $25+ stock within 1 year and may even get buyout offer down the road. LOAD UP now and you will be amazed with the strong returns down the road

Summary: Strong buy on TSSI; targets $25+ within a year, possible buyout catalyst, urges loading up now.

$TSSI $11.75 - Will be $25+ stock within 1 year and may even get buyout offer down the road. I see stock definitely rising just like $HIMS have which was dead between $7 - $17 then it went up very strongly to $72+ so if you have patience, LOAD UP now and you will be amazed with the strong returns down the road in LT imo  🤑
#SupDup


Summary: Expects ORKT to be the next mover, implied bullish following RNAZ's run.

$RNAZ - $10.50  rn  🤑
$ORKT next imo
#SupDup


Summary: Bullish RKLB on $5.6B U.S. Air Force contract award.

$RKLB - Rocket Lab USA and Stoke Space Technologies awarded $5.6 bln U.S. Air Force contract imo   🤑
#SupDup


Summary: Loading up NIXX under $2 with a long-term target of $10+.

$NIXX <$2 - I am loading up for ST, NT & LT as I see it rising to $10+ one day in future imo  🤑
 #SupDup


Summary: Expects ALLR to reach $1.20–$1.50 tomorrow from current ~$1.

$ALLR $1 - My instinct says tomorrow we will see $1.20 - $1.50 imo
#SupDup


Summary: Hold and add on dips; bullish stance on KSCP.


Summary: Long KPRX; current fundamentals justify $5–$10, long-term target $15–$25 on thin float and biotech catalyst potential.

$KPRX - Should not be <$3 but even today should be trading between $5 - $10 based on its current strong fundamentals. Down the road this could be a jackpot for biotech/pharma sector investors with vision & PAYtience. In LT this could be $15 - $25 stock. Float is razor thin so any good news will make this take off like a   🚀  just like how it had upon the last PR that made it jump to ~$7 imo
#SupDup


Summary: Actively buying and adding to SOUN position at $9.85–$9.95.

$SOUN - Bought $9.85 - $9.95 and adding even more.
#SupDup


Summary: Expects EDBL to spike 25–100% within a week.

$EDBL - Could possibly spike 25% - 100% within a week imo   🤑
#SupDup


Summary: Strong buy KPRX at <$3.35; multiple catalysts expected to push to $7–$10 near-term, cash exceeds mkt cap, thin float, no dilution risk.

$KPRX <$3.35 rn after earlier spike to $7.70 = Time for me to LOAD LOAD LOAD. Multiple data read outs coming within months which should push this to $7 - $10 range in NT. Remember float is very thin here and ample cash on hand to last till end of 2027 so no worries about dilution. More cash on hand currently than company’s value giving it ZERO value for its rich advanced eye diseases drug discovery pipeline with multiple licensing deals in place including one with European Thea that pays for the clinical trials. This is ABSOLUTE BARGAIN BUY at current low valuation for ST, NT & LT investors imo.
#SupDup


Summary: Adding to MOB position on dips; bullish accumulation stance.


Summary: Bullish on KSCP following US Air Force autonomous robotics partnership announcement.

$KSCP - NEWS !!  HOLLY MOLLY
Partners with US AIR FORCE for autonomous Robots imo   🤑
#SupDup

https://t.co/2ZCDCmRIHL


Summary: Still holding LAES as a long-term position.

@SuperDuperInvst $LAES still holding? LT?


Summary: Bullish RNAZ with a new upside target of $1.25–$1.75, upgrading from prior $1 call after stock hit $1.15 in pre-market.

$RNAZ - Marching towards $1.25 - $1.75 imo
Yesterday when it was $0.80 I predicted stock was marching towards $1 and so far it went to $1.15 in pre mkt   🤑
#SupDup

https://t.co/mOL9DpOJlI

$RNAZ - ⚡ Marching towards $1   😍   imo    🤑
#SupDup


Summary: MOB will double similarly to ESLT's run, per author's view.

$ESLT $463 rn   🤑
$MOB will double too just similarly over the time imo
#SupDup

$ESLT ~$230 today - UP ~$20 today  😍
I traded a few times between $190 - $205 but I didn't mention about it here since its a war related defense sector play.
#SupDup


Summary: Expects a strategic partnership or licensing deal for RNAZ in Q4 or early 2026, driven by TTX-MC138 anti-metastatic data.

$RNAZ - I expect strategic partnership or licensing deal in 4th qtr or early 2026 imo.
90% of Cancer deaths are due to Metastatis as per reports.
TTX-MC138 has shown complete regressions of metastatic disease in multiple preclinical studies.
#SupDup